APRIL SZYMANSKI: Open Payments
NPI 1942435821 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$156 in 4 payments from 4 companies in 2025. Trend: 2023 $140 · 2024 $32 · 2025 $156
Food & beverage: $156
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 1 | $75 |
| ARGENX US, INC. | 1 | $35 |
| Genentech USA, Inc. | 1 | $25 |
| Alexion Pharmaceuticals, Inc. | 1 | $21 |
Products named: QALSODY, VYVGART HYTRULO, Ocrevus Zunovo, ULTOMIRIS.
Industry payments across IL — which companies pay providers there.
